
On December 11th, the United States District Court for the Northern District of California denied motions to dismiss the False Claims Act lawsuit regarding pharmaceutical companies Allergan and Adamas. Allergan and Adamas allegedly falsified data in order to obtain a series of patents for two medications: Namenda XR and Namzaric.... Read More »